dihexa half-life halflife targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c-MET receptor, it helps cells take in nutrients and rebuild—especially in cases where recovery is slow dihexa half-life pharmacokinetics and Pharmacodynamics:

FDA-Approved Clinical Indications Primary Indication: B12 deficiency-related peripheral neuropathy and subacute combined degeneration

A comprehensive autoimmune protocol might include continuous immune-modulating peptides like thymosin alpha-1 or KPV for ongoing immune regulation, combined with periodic bioregulator courses to support organ health and recovery

Call your doctor if you experience any of the following symptoms: Headache Nausea Drowsiness Numbness Tingling in the arms and/or legs Seek immediate medical attention if you experience any of the following: Rash Itching Swelling Severe dizziness Trouble breathing Storage Store at controlled room temperature

That does not mean it is ineffective for the right patient